{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:26:11Z","timestamp":1790342771886,"version":"4.1.0"},"reference-count":83,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy of Craiova, Romania"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Adiponectin and omentin are adipose tissue-derived adipokines implicated in insulin sensitivity and cardiometabolic regulation. Their behavior across different stages of dysglycemia, as well as in relation to visceral adiposity and cardiometabolic phenotypes, remains incompletely understood. In this cross-sectional study, circulating adiponectin and omentin levels were evaluated in individuals with prediabetes (PreDM, n = 100) and newly diagnosed type 2 diabetes mellitus (T2DM, n = 128). Associations with insulin resistance-related indices, including the triglyceride\u2013glucose (TyG) index and TyG-derived composites, the visceral adiposity index (VAI), cardiometabolic phenotypes, and cardiovascular risk categories, were assessed using correlation and multivariable regression analyses. Discriminatory performance for metabolically unhealthy obesity was evaluated using receiver operating characteristic (ROC) curve analysis. Both adiponectin and omentin levels were lower in T2DM compared with PreDM (22.05 vs. 30.30 and 25.72 vs. 38.84, p &lt; 0.0001 for both). In PreDMs, omentin showed a significant inverse correlation with the TyG index (weak correlation, \u03c1 = \u22120.197, p = 0.050), whereas adiponectin demonstrated only weak trends. In multivariable models, VAI and male sex were independent predictors of circulating omentin levels, whereas fasting insulin was not. In contrast, adiponectin did not retain independent associations with metabolic or visceral adiposity indices. In T2DM, adipokine\u2013metabolic associations were largely absent. Neither adipokine differed substantially across cardiometabolic phenotypes or cardiovascular risk categories. ROC analyses revealed modest overall discriminatory performance for metabolically obese phenotypes, with poor discrimination after stratification by glycemic status (area under the ROC curve (AUC) of 0.704 for adiponectin and 0.710 for omentin, and AUC of 0.431 for adiponectin and 0.461 for omentin, respectively). Circulating adipokines appear to exhibit stage-dependent relationships with metabolic dysfunction, being more informative in PreDM than in established T2DM. Omentin may reflect visceral adiposity-related metabolic alterations in early dysglycemia, whereas adiponectin shows limited independent associations. Overall, these findings suggest that adipokines have limited diagnostic or cardiovascular risk-stratification utility when considered in isolation and may be better interpreted within multimarker cardiometabolic assessment frameworks.<\/jats:p>","DOI":"10.3390\/ijms27062558","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:00:37Z","timestamp":1773219637000},"page":"2558","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Circulating Adiponectin and Omentin Across Cardiometabolic Phenotypes: Links to Atherogenic Indices in Prediabetes and New-Onset Type 2 Diabetes"],"prefix":"10.3390","volume":"27","author":[{"given":"Daniela Denisa","family":"Mitroi Sakizlian","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ciobanu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4817-1365","authenticated-orcid":false,"given":"Lidia","family":"Boldeanu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3146-8769","authenticated-orcid":false,"given":"Mohamed-Zakaria","family":"Assani","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"},{"name":"Department of Immunology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Silo\u0219i","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7398-5689","authenticated-orcid":false,"given":"Vlad","family":"P\u0103dureanu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Cosmin","family":"Caragea","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venera Cristina","family":"Dinescu","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Occupational Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina Elena","family":"Ciobanu Plasiciuc","sequence":"additional","affiliation":[{"name":"Department of Health and Motricity, Faculty of Medical and Behavioral Sciences, \u201cConstantin Br\u00e2ncu\u0219i\u201d University of T\u00e2rgu-Jiu, 210185 T\u00e2rgu-Jiu, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s11154-023-09813-5","article-title":"Obesity phenotypes and cardiovascular risk: From pathophysiology to clinical management","volume":"24","author":"Preda","year":"2023","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Roberson, L.L., Aneni, E.C., Maziak, W., Agatston, A., Feldman, T., Rouseff, M., Tran, T., Blaha, M.J., Santos, R.D., and Sposito, A. (2014). Beyond BMI: The \u201cMetabolically healthy obese\u201d phenotype & its association with clinical\/subclinical cardiovascular disease and all-cause mortality\u2014A systematic review. BMC Public Health, 14.","DOI":"10.1186\/1471-2458-14-14"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2147\/DMSO.S449213","article-title":"Metabolically Unhealthy Normal Weight: Prevalence and Associated Factors in an Adult Population from Northwest Colombia","volume":"17","author":"Castillo","year":"2024","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41043-025-00761-1","article-title":"Relationship between dietary intake and atherogenic index of plasma in cardiometabolic phenotypes: A cross-sectional study from the Azar cohort population","volume":"44","author":"Soheilifard","year":"2025","journal-title":"J. Health Popul. Nutr."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mitroi Sakizlian, D.D., Boldeanu, L., Mitrea, A., Clenciu, D., Vladu, I.M., Ciobanu Plasiciuc, A.E., \u0218arla, A.V., Silo\u0219i, I., Boldeanu, M.V., and Assani, M.-Z. (2025). The Interplay of Cardiometabolic Syndrome Phenotypes and Cardiovascular Risk Indices in Patients Diagnosed with Diabetes Mellitus. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136227"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"102635","DOI":"10.1016\/j.dsx.2022.102635","article-title":"Metabolically unhealthy phenotype in normal weight population and risk of mortality and major adverse cardiac events: A meta-analysis of 41 prospective cohort studies","volume":"16","author":"Putra","year":"2022","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12933-023-01815-6","article-title":"Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study","volume":"22","author":"Wei","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.orcp.2023.02.001","article-title":"Metabolically unhealthy phenotype in adults with normal weight: Is cardiometabolic health worse off when compared to adults with obesity?","volume":"17","author":"Seo","year":"2023","journal-title":"Obes. Res. Clin. Pract."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Jung, H.N., and Jung, C.H. (2021). The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413529"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/adip.27552","article-title":"Adipokines and insulin action: A sensitive issue","volume":"3","author":"Knights","year":"2014","journal-title":"Adipocyte"},{"key":"ref_11","first-page":"430","article-title":"Adiponectin: An adipokine with protective features against metabolic syndrome","volume":"18","author":"Esfahani","year":"2015","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pcad.2009.06.004","article-title":"Antiatherosclerotic and anti-insulin resistance effects of adiponectin: Basic and clinical studies","volume":"52","author":"Han","year":"2009","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Begum, M., Choubey, M., Tirumalasetty, M.B., Arbee, S., Mohib, M.M., Wahiduzzaman, M., Mamun, M.A., Uddin, M.B., and Mohiuddin, M.S. (2023). Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications. Life, 13.","DOI":"10.20944\/preprints202310.0782.v1"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Eltahir, H.B., Ali, E.M., and Mohamed, A.O. (2025). Association of serum adiponectin level with glycemic control and atherogenic lipid profile in Sudanese patients with type 2 diabetes mellitus. BMC Endocr. Disord., 25.","DOI":"10.1186\/s12902-025-02053-5"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sun, Q., Yan, B., Yang, D., Guo, J., Wang, C., Zhang, Q., Shi, Y., Shi, X., Tian, G., and Liang, X. (2020). Serum Adiponectin Levels Are Positively Associated With Diabetic Peripheral Neuropathy in Chinese Patients With Type 2 Diabetes. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.567959"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jdiacomp.2015.11.004","article-title":"Association between circulating adipocytokine concentrations and microvascular complications in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of controlled cross-sectional studies","volume":"30","author":"Nunes","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"ref_17","first-page":"257","article-title":"Determination of Serum Adiponectin Levels in Type 2 Diabetes Patients of the Saudi Population in the Al-Jouf Region","volume":"27","author":"Alzahrani","year":"2020","journal-title":"Rom. J. Diabetes Nutr. Metab. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4103\/jomfp.JOMFP_87_18","article-title":"Assessment of serum and salivary adiponectin levels in newly diagnosed Type II diabetes mellitus patients","volume":"24","author":"Kalyani","year":"2020","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"ref_19","first-page":"e27308","article-title":"Adiponectin Can Be an Early Predictable Marker for Type 2 Diabetes Mellitus and Nephropathy","volume":"14","author":"Ganesh","year":"2022","journal-title":"Cureus"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"107514","DOI":"10.1016\/j.carpath.2022.107514","article-title":"The role of adiponectin in cardiovascular disease","volume":"64","author":"Peng","year":"2023","journal-title":"Cardiovasc. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yan, Y., Wang, L., Zhong, N., Wen, D., and Liu, L. (2024). Multifaced roles of adipokines in endothelial cell function. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1490143"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2174\/1570161112999140217095038","article-title":"Omentin: Linking metabolic syndrome and cardiovascular disease","volume":"12","author":"Zhou","year":"2014","journal-title":"Curr. Vasc. Pharmacol. B"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sena, C.M. (2024). Omentin: A Key Player in Glucose Homeostasis, Atheroprotection, and Anti-Inflammatory Potential for Cardiovascular Health in Obesity and Diabetes. Biomedicines, 12.","DOI":"10.3390\/biomedicines12020284"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1080\/02701367.2022.2070116","article-title":"Aerobic Exercise Training Effects on Omentin-1, Insulin Resistance, and Lipid Profile Among Male Smokers","volume":"94","author":"Mousavi","year":"2023","journal-title":"Res. Q. Exerc. Sport"},{"key":"ref_25","first-page":"6777283","article-title":"A Randomized Trial with Two Hypocaloric Diets with Different Lipid Profiles and Effects on Serum Omentin-1 Levels in Obese Subjects","volume":"2022","author":"Izaola","year":"2022","journal-title":"Dis. Markers"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Karvane, H.B., Esfandiari, H., Qutaiba, O., Allela, B., Mahdi, M.S., Al-Nuaimi, A.M.A., Al-Hussein, R.K.A., Jawad, M.J., Ghayourvahdat, A., and Keshavarzian, A. (2024). Metabolic syndrome in association with novel dietary index, metabolic parameters, nesfatin-1 and omentin-1. BMC Endocr. Disord., 24.","DOI":"10.1186\/s12902-024-01791-2"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zhang, J., Wang, C., Yang, Z., Xiao, Y., Mi, X., and Zhu, L. (2023). Correlations of Omentin-1 and Leptin with Bone Metabolism and Plasma Glucose Upon Type 2 Diabetes Mellitus and Osteoporosis. Clin. Lab., 69.","DOI":"10.7754\/Clin.Lab.2022.220603"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Amirkhizi, F., Khademi, Z., Hamedi Shahraki, S., and Rahimlou, M. (2023). Vitamin D insufficiency and its association with adipokines and atherogenic indices in patients with metabolic syndrome: A case-control study. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1080138"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12291-018-0784-4","article-title":"New Biomarkers as Prognostic Factors for Cardiovascular Complications in Type 2 Diabetic Patients","volume":"35","author":"Ahmed","year":"2020","journal-title":"Indian J. Clin. Biochem."},{"key":"ref_30","first-page":"14","article-title":"Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control, insulin resistance and metabolic parameters","volume":"13","author":"Elsaid","year":"2018","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_31","first-page":"BC10","article-title":"Plasma omentin-1 level and its relationship with insulin resistance in obese prediabetics","volume":"12","author":"Kaushik","year":"2018","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1139\/cjpp-2017-0272","article-title":"Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis","volume":"96","author":"Motawi","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"20170031","DOI":"10.1515\/hmbci-2017-0031","article-title":"Classical (adiponectin, leptin, resistin) and new (chemerin, vaspin, omentin) adipocytokines in patients with prediabetes","volume":"34","author":"Gateva","year":"2018","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Greulich, S., Chen, W.J., Maxhera, B., Rijzewijk, L.J., van der Meer, R.W., Jonker, J.T., Mueller, H., de Wiza, D.H., Floerke, R.R., and Smiris, K. (2013). Cardioprotective properties of omentin-1 in type 2 diabetes: Evidence from clinical and in vitro studies. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059697"},{"key":"ref_35","first-page":"207","article-title":"Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: The effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy","volume":"63","author":"Trachta","year":"2014","journal-title":"Physiol. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ando.2014.04.013","article-title":"Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults","volume":"75","author":"Zhang","year":"2014","journal-title":"Ann. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhang, Y., He, Q., Zhang, W., Xiong, Y., Shen, S., Yang, J., and Ye, M. (2022). Non-linear Associations Between Visceral Adiposity Index and Cardiovascular and Cerebrovascular Diseases: Results From the NHANES (1999\u20132018). Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.908020"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zhou, H., Li, T., Li, J., Zheng, D., Yang, J., and Zhuang, X. (2024). Association of visceral adiposity index with hypertension (NHANES 2003\u20132018). Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1341229"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhang, J., Li, M., Wang, T., Tian, W., Ju, J., and Xu, H. (2025). Association between visceral adiposity index and all-cause and cardiovascular mortality in the non-elderly adults. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1523731"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Jakubiak, G.K., Badicu, G., Surma, S., Waluga-Koz\u0142owska, E., Chwalba, A., and Pawlas, N. (2025). The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders. Nutrients, 17.","DOI":"10.3390\/nu17142374"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hudzik, B., Nowak, J., Szkodzi\u0144ski, J., and Zubelewicz-Szkodzi\u0144ska, B. (2021). Visceral Adiposity in Relation to Body Adiposity and Nutritional Status in Elderly Patients with Stable Coronary Artery Disease. Nutrients, 13.","DOI":"10.3390\/nu13072351"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e70007","DOI":"10.1002\/edm2.70007","article-title":"Atherogenic Index of Plasma (AIP): The Most Accurate Indicator of Overweight and Obesity Among Lipid Indices in Type 2 Diabetes-Findings From a Cross-Sectional Study","volume":"7","author":"Yadegar","year":"2024","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Papathanasiou, K.A., Roussos, C.E., Armylagos, S., Rallidis, S.L., and Rallidis, L.S. (2024). Lipid Accumulation Product Is Predictive of Cardiovascular Hospitalizations among Patients with Stable Ischemic Heart Disease: Long-Term Follow-Up of the LAERTES Study. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11100316"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e060377","DOI":"10.1136\/bmjopen-2021-060377","article-title":"Association between adiponectin and newly diagnosed type 2 diabetes in population with the clustering of obesity, dyslipidaemia and hypertension: A cross-sectional study","volume":"13","author":"Hong","year":"2023","journal-title":"BMJ Open"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"108008","DOI":"10.1016\/j.pharmthera.2021.108008","article-title":"The adiponectin signalling pathway\u2014A therapeutic target for the cardiac complications of type 2 diabetes?","volume":"232","author":"Sharma","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-025-01610-5","article-title":"The Cardioprotective Effects of Adiponectin in Diabetes","volume":"25","author":"Kazemi","year":"2025","journal-title":"Curr. Diab. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Pan, X., Kaminga, A.C., Wen, S.W., Acheampong, K., and Liu, A. (2019). Omentin-1 in diabetes mellitus: A systematic review and meta-analysis. PLoS ONE, 14.","DOI":"10.2139\/ssrn.3353383"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2147\/DMSO.S206981","article-title":"The association between omentin and diabetes: A systematic review and meta-analysis of observational studies","volume":"12","author":"Sadeghi","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Sperling, M., Grzelak, T., Pelczy\u0144ska, M., Bogda\u0144ski, P., Formanowicz, D., and Czy\u017cewska, K. (2023). Association of Serum Omentin-1 Concentration with the Content of Adipose Tissue and Glucose Tolerance in Subjects with Central Obesity. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020331"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e003865","DOI":"10.1136\/bmjdrc-2023-003865","article-title":"Omentin associates with serum metabolite profiles indicating lower diabetes risk: KORA F4 Study","volume":"12","author":"Shi","year":"2024","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lejawa, M., Osadnik, K., Czuba, Z., Osadnik, T., and Pawlas, N. (2021). Association of Metabolically Healthy and Unhealthy Obesity Phenotype with Markers Related to Obesity, Diabetes among Young, Healthy Adult Men. Analysis of MAGNETIC Study. Life, 11.","DOI":"10.3390\/life11121350"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejim.2023.02.025","article-title":"Metabolically healthy obesity: Misleading phrase or healthy phenotype?","volume":"111","author":"Tanriover","year":"2023","journal-title":"Eur. J. Intern. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1038\/s41598-025-93922-5","article-title":"Association between TyG index with obesity indicators and coronary heart disease: A cohort study","volume":"15","author":"Miao","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Yan, S., Dong, W., Niu, Y., Song, L., Pang, P., Sun, D., Zhang, Y., Wang, W., Hu, H., and Jin, X. (2025). Associations of the triglyceride-glucose index and triglyceride-glucose\/body mass index with all-cause mortality in Chinese centenarians. BMC Geriatr., 25.","DOI":"10.1186\/s12877-025-05894-w"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Hamedi-Shahraki, S., Klisic, A., Amirkhizi, F., and Mercantepe, F. (2026). Association of the triglyceride-glucose index with inflammatory markers and dysregulation of adipokines in patients with metabolic syndrome. BMC Endocr. Disord., 26.","DOI":"10.1186\/s12902-025-02142-5"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Li, S., Han, X., Song, J., Dong, M., and Xie, T. (2024). Mechanism of Action and Risk Prediction of Adiponectin in Cardiovascular Diseases. Front. Biosci., 29.","DOI":"10.31083\/j.fbl2908286"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Accacha, S., Barillas-Cerritos, J., Gabriel, L., Srivastava, A., Gulkarov, S., Apsan, J.A., De Leon, J., and Reiss, A.B. (2026). The Natural History of Prediabetes and Cardiovascular Disease in the Pediatric Population. Biomedicines, 14.","DOI":"10.3390\/biomedicines14010198"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1017\/S136898001800335X","article-title":"Visceral adiposity index is a better predictor of unhealthy metabolic phenotype than traditional adiposity measures: Results from a population-based study","volume":"22","author":"Ferreira","year":"2019","journal-title":"Public Health Nutr."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Jiang, K., Luan, H., Pu, X., Wang, M., Yin, J., and Gong, R. (2022). Association Between Visceral Adiposity Index and Insulin Resistance: A Cross-Sectional Study Based on US Adults. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.921067"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/13813455.2023.2283685","article-title":"Omentin roles in physiology and pathophysiology: An up-to-date comprehensive review","volume":"130","author":"Hussein","year":"2024","journal-title":"Arch. Physiol. Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"11145","DOI":"10.1007\/s00210-025-04008-y","article-title":"Omentin-1 as a promising biomarker and therapeutic target in hypertension and heart failure: A comprehensive review","volume":"398","author":"Zamanian","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Lu\u00eds, C., Baylina, P., Soares, R., and Fernandes, R. (2021). Metabolic Dysfunction Bi-omarkers as Predictors of Early Diabetes. Biomolecules, 11.","DOI":"10.3390\/biom11111589"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dbi25-0006","article-title":"Pathobiology of Prediabetes: Understanding and Interrupting Progressive Dysglycemia and Associated Complications","volume":"74","year":"2025","journal-title":"Diabetes"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Biega\u0144ski, H.M., D\u0105browski, K.M., and R\u00f3\u017ca\u0144ska-Wal\u0119dziak, A. (2025). Omentin-General Overview of Its Role in Obesity, Metabolic Syndrome and Other Diseases; Problem of Current Research State. Biomedicines, 13.","DOI":"10.3390\/biomedicines13030632"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"22286","DOI":"10.1038\/s41598-024-72720-5","article-title":"Expression of Intelectin-1, also known as Omentin-1, is related to clinical phenotypes such as overweight, obesity, insulin resistance, and changes after bariatric surgery","volume":"14","author":"Czechowski","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"20420188231222371","DOI":"10.1177\/20420188231222371","article-title":"Therapeutic potential of adiponectin in prediabetes: Strategies, challenges, and future directions","volume":"15","author":"Abdalla","year":"2024","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"bnaa004","DOI":"10.1210\/endrev\/bnaa004","article-title":"Metabolically Healthy Obesity","volume":"41","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Assani, M.Z., Novac, M.B., Dijm\u0103rescu, A.L., V\u0103duva, C.C., Vladu, I.M., Clenciu, D., Mitrea, A., Ahri\u021bculesei, R.V., Stroe-Ionescu, A.\u0218., and Assani, A.D. (2025). Potential Association Between Atherogenic Coefficient, Prognostic Nutritional Index, and Various Obesity Indices in Diabetic Nephropathy. Nutrients, 17.","DOI":"10.3390\/nu17081339"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025. Diabetes Care, 48, S27\u2013S49.","DOI":"10.2337\/dc25-S002"},{"key":"ref_70","unstructured":"World Health Organization (2008). Waist Circumference and Waist\u2013Hip Ratio: Report of a WHO Expert Consultation, WHO."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e023667","DOI":"10.1161\/JAHA.121.023667","article-title":"Body Mass Index and Association With Cardiovascular Outcomes in Patients With Stable Coronary Heart Disease\u2014A STABILITY Substudy","volume":"11","author":"Held","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_73","unstructured":"(2025, December 05). CalculatedBody. Available online: https:\/\/calculatedbody.com\/blood\/homeostatic-model-assessment-insulin-resistance\/."},{"key":"ref_74","unstructured":"(2025, December 05). CalculatedBody. Available online: https:\/\/calculatedbody.com\/blood\/quantitative-insulin-sensitivity-check-index\/."},{"key":"ref_75","unstructured":"(2025, December 05). CalculatedBody. Available online: https:\/\/calculatedbody.com\/blood\/atherogenic-index-plasma\/."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1515\/med-2022-0590","article-title":"Atherogenic index of plasma and coronary artery disease: A systematic review","volume":"17","year":"2022","journal-title":"Open Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Shan, Y., Lin, M., Gu, F., Li, D., Zhu, Q., Chen, Z., Zhang, W., Fu, G., and Wang, M. (2025). The prognostic association of triglyceride-glucose index and its derived indicators with stable coronary artery disease patients undergoing percutaneous coronary intervention. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1465376"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12933-025-02657-0","article-title":"Insights into the complex relationship between triglyceride glucose-waist height ratio index, mean arterial pressure, and cardiovascular disease: A nationwide prospective cohort study","volume":"24","author":"Xu","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2147\/DMSO.S509721","article-title":"TyG-WC Index as a Superior Predictor of Hyperuricemia Risk in the Hypertensive Population: A Prospective Cohort Study","volume":"18","author":"Zhang","year":"2025","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: The Framingham Heart Study","volume":"117","author":"Vasan","year":"2008","journal-title":"Circulation"},{"key":"ref_81","unstructured":"(2025, December 05). MDCalc. Available online: https:\/\/www.mdcalc.com\/calc\/38\/framingham-risk-score-hard-coronary-heart-disease#evidence."},{"key":"ref_82","unstructured":"WHO CVD Risk Chart Working Group (2019). World Health Organization cardiovascular disease risk charts: Revised models to estimate risk in 21 global regions. Lancet Glob Health, 7, e1332\u2013e1345."},{"key":"ref_83","unstructured":"WHO (2025, December 05). Available online: https:\/\/extranet.who.int\/whoncdspenwp\/RiskCalculator."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2558\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:02:58Z","timestamp":1773219778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":83,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27062558"],"URL":"https:\/\/doi.org\/10.3390\/ijms27062558","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}